Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
CALL
Cleveland-Cliffs
CLF
$6.57B
| $175K | ﹤0.01% |
8,720
-80,360
| -90% | -$1.31M |
|
|
ESSA
3727
DELISTED
ESSA Bancorp
ESSA
| $175K | ﹤0.01% |
10,923
+4,576
| +72% | +$72.2K |
|
3728
Harvard Bioscience
HBIO
$27.5M
| $174K | ﹤0.01% |
3,201
+1,634
| +104% | +$79.5K |
|
3729
Mayville Engineering Co
MEC
$654M
| $174K | ﹤0.01% |
12,099
+3,776
| +45% | +$55.7K |
|
3730
Xeris Biopharma Holdings
XERS
$1.39B
| $174K | ﹤0.01% |
38,750
+23,747
| +158% | +$128K |
|
|
TAST
3731
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $174K | ﹤0.01% |
29,164
+17,903
| +159% | +$117K |
|
|
SLAI
3732
DELISTED
SOLAI Ltd ADS
SLAI
| $173K | ﹤0.01% |
+116
| New | +$147K |
|
3733
Preformed Line Products
PLPC
$1.75B
| $173K | ﹤0.01% |
2,516
+1,545
| +159% | +$108K |
|
3734
Schwab US Large- Cap ETF
SCHX
$71.8B
| $173K | ﹤0.01% |
+10,788
| New | +$169K |
|
|
EXTN
3735
DELISTED
Exterran Corporation
EXTN
| $173K | ﹤0.01% |
51,565
+19,927
| +63% | +$92.3K |
|
3736
Rimini Street
RMNI
$449M
| $172K | ﹤0.01% |
19,205
+11,789
| +159% | +$91.2K |
|
3737
USA Compression Partners
USAC
$3.79B
| $172K | ﹤0.01% |
11,211
+56
| +0.5% | +$820 |
|
|
PTVCB
3738
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $172K | ﹤0.01% |
7,506
+2,339
| +45% | +$44.3K |
|
|
FLNT
3739
Fluent
FLNT
$102M
| $171K | ﹤0.01% |
6,968
+4,718
| +210% | +$164K |
|
3740
FVCBankcorp
FVCB
$335M
| $171K | ﹤0.01% |
12,340
+7,576
| +159% | +$101K |
|
3741
Freedom Holding
FRHC
$9.63B
| $170K | ﹤0.01% |
+3,178
| New | +$167K |
|
3742
Perion Network
PERI
$375M
| $170K | ﹤0.01% |
9,524
+2,424
| +34% | +$43.8K |
|
|
BOCH
3743
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $170K | ﹤0.01% |
13,297
+8,162
| +159% | +$90.3K |
|
3744
AudioEye
AEYE
$72.3M
| $169K | ﹤0.01% |
+6,059
| New | +$178K |
|
3745
Castor Maritime
CTRM
$18.8M
| $169K | ﹤0.01% |
2,225
| – | – |
|
3746
iShares MSCI Poland ETF
EPOL
$700M
| $169K | ﹤0.01% |
9,360
+7,375
| +372% | +$141K |
|
3747
Northeast Bank
NBN
$1.06B
| $169K | ﹤0.01% |
6,406
+3,989
| +165% | +$107K |
|
3748
Village Super Market
VLGEA
$651M
| $169K | ﹤0.01% |
7,168
+4,400
| +159% | +$102K |
|
3749
eGain
EGAN
$187M
| $168K | ﹤0.01% |
17,656
+10,930
| +163% | +$122K |
|
|
AMJ
3750
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $167K | ﹤0.01% |
10,052
| – | – |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.